SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
SpartanNash Company (SPTN) trades at a trailing P/E of 2,690.0, forward P/E of 15.5. Trailing earnings yield is 0.04%, forward earnings yield 6.47%.
Criteria proven by this page:
- VALUE (34/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 2,690.0); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.04%).
- Forward P/E 15.5 (down from trailing 2,690.0) — analysts expect earnings to grow, which would improve the valuation.
- Trailing Earnings Yield 0.04% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 6.47% as earnings recover.
- Analyst consensus target $27.50 (+2.2% upside) — modest upside expected.
Overall SharesGrow Score: 45/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
34/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SPTN
Valuation Multiples
P/E (TTM)2,690.0
Forward P/E15.5
PEG RatioN/A
Forward PEG0.00
P/B Ratio0.00
P/S Ratio0.10
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.01
Forward EPS (Est.)$1.74
Book Value / Share$0.00
Revenue / Share$279.18
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.04%
Forward Earnings Yield6.47%
Dividend Yield0.00%
Analyst Target$27.50 (+2.2%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$1.66 |
$7.65B |
$62.71M |
0.8% |
| 2016 |
$1.51 |
$7.73B |
$56.83M |
0.7% |
| 2017 |
$-1.41 |
$8.13B |
$-52.85M |
-0.7% |
| 2018 |
$0.95 |
$8.06B |
$33.57M |
0.4% |
| 2019 |
$0.16 |
$8.54B |
$5.74M |
0.1% |
| 2020 |
$2.12 |
$9.35B |
$75.91M |
0.8% |
| 2021 |
$2.05 |
$8.93B |
$73.75M |
0.8% |
| 2022 |
$0.95 |
$9.64B |
$34.52M |
0.4% |
| 2023 |
$1.20 |
$7.48B |
$41.93M |
0.6% |
| 2024 |
$0.01 |
$9.55B |
$299K |
0% |
